|
Wegovy Oral Pill Launches in United States
|
Written by: J. Smith |
Hits: 92
|
|
FDA Approves First Oral GLP-1 for Chronic Weight Management
|
Written by: J. Smith |
Hits: 124
|
|
Retatrutide Delivers Phase 3 Success and Signals Lilly’s Strategic Positioning
|
Written by: J. Smith |
Hits: 297
|
|
Novo Nordisk Seeks FDA Approval for Higher 7.2 mg Dose of Wegovy
|
Written by: J. Smith |
Hits: 119
|
|
Novo Nordisk Reports Strong Phase 2 Results for Amycretin in Type 2 Diabetes
|
Written by: J. Smith |
Hits: 110
|
|
Oral Semaglutide Does Not Slow Alzheimer’s Progression: How Today’s Results Fit the Larger Story
|
Written by: J. Smith |
Hits: 170
|
|
Zealand Pharma Pauses Development of Dapiglutide
|
Written by: J. Smith |
Hits: 191
|
|
Innovent’s Mazdutide Outperforms Semaglutide in Head-to-Head Trial
|
Written by: J. Smith |
Hits: 160
|
|
Semaglutide’s Heart Benefits Extend Beyond Weight Loss
|
Written by: J. Smith |
Hits: 98
|
|
Terns Ends Development of Oral Obesity Drug After Phase 2 Results
|
Written by: J. Smith |
Hits: 161
|
